Block Listing Update
11 May 2015
Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology announces that, since the last update in November 2014, there have been no changes to the numbers of shares block listed in respect of the Company's two option plans. All ordinary shares of 0.2 pence each.
The table below provides further detail.
|Name of company:||Futura Medical plc|
|Name of scheme:||Unapproved Share Option Scheme ("USOS")
EMI Share Option Scheme ("EMI")
|Period of return:||From:||11 November 2014|
|To:||11 May 2015|
|Number and class of securities not issued under the scheme(s)||USOS:||1,786,435|
|Number of securities issued under the scheme(s) during the period Number of securities lapsed under the scheme(s) during the period||USOS:||Nil|
|EMI: USOS: EMI: Total:||Nil 345,835 434,165 780,000|
|Balance under the scheme(s) of securities not yet issued at the end of the period||USOS:||1,440,600|
|Number and class of securities originally admitted and the date of admission||USOS:||814,424 on 25 May 2011 and 1,202,280 on 8 October 2013|
|EMI:||1,520,576 on 25 May 2011 and 1,467,720 on 8 October 2013|
|Name of contact:||Derek Martin, Chief Financial Officer|
|Telephone number of contact:||+44 (0) 1483 685 670|
For further information please contact:
Aubrey Powell / Liz Yong / Thomas Smale
Tel: +44 (0) 20 7496 3000
For media enquiries please contact:
Buchanan Communications Limited
Mark Court / Sophie Cowles /
Tel: +44 (0) 20 7466 5000
Notes to editors:
About Futura Medical plc
Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.
Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.